These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 12394693

  • 1. Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy.
    Kestin LL, Goldstein NS, Vicini FA, Martinez AA.
    J Urol; 2002 Nov; 168(5):1994-9. PubMed ID: 12394693
    [Abstract] [Full Text] [Related]

  • 2. Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy.
    Kestin LL, Goldstein NS, Vicini FA, Mitchell C, Gustafson GS, Stromberg JS, Chen PY, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2002 Sep 01; 54(1):107-18. PubMed ID: 12182980
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Optimized prostate brachytherapy minimizes the prognostic impact of percent of biopsy cores involved with adenocarcinoma.
    Nurani R, Wallner K, Merrick G, Virgin J, Orio P, True LD.
    J Urol; 2007 Nov 01; 178(5):1968-73; discussion 1973. PubMed ID: 17868717
    [Abstract] [Full Text] [Related]

  • 5. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
    Martinez AA, Kestin LL, Stromberg JS, Gonzalez JA, Wallace M, Gustafson GS, Edmundson GK, Spencer W, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2000 May 01; 47(2):343-52. PubMed ID: 10802358
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
    Wong WW, Schild SE, Vora SA, Halyard MY.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):24-9. PubMed ID: 15337536
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome.
    Kupelian PA, Buchsbaum JC, Elshaikh MA, Reddy CA, Klein EA.
    Int J Radiat Oncol Biol Phys; 2003 Nov 01; 57(3):629-34. PubMed ID: 14529766
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Percent positive biopsy cores as a prognostic factor for prostate cancer treated with external beam radiation.
    Spalding AC, Daignault S, Sandler HM, Shah RB, Pan CC, Ray ME.
    Urology; 2007 May 01; 69(5):936-40. PubMed ID: 17482938
    [Abstract] [Full Text] [Related]

  • 12. Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy.
    Vance SM, Stenmark MH, Blas K, Halverson S, Hamstra DA, Feng FY.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):940-6. PubMed ID: 22056069
    [Abstract] [Full Text] [Related]

  • 13. Prostate-specific antigen cancer volume: a significant prognostic factor in prostate cancer patients at intermediate risk of failing radiotherapy.
    Lankford SP, Pollack A, Zagars GK.
    Int J Radiat Oncol Biol Phys; 1997 May 01; 38(2):327-33. PubMed ID: 9226319
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.
    Cancer J; 2001 May 01; 7(5):404-12. PubMed ID: 11693899
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score.
    Freedland SJ, Csathy GS, Dorey F, Aronson WJ.
    J Urol; 2002 Feb 01; 167(2 Pt 1):516-20. PubMed ID: 11792909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.